文献速递帕金森病与运动障碍

体重指数与帕金森病的关联:双向孟德尔随机化研究

Association of Body Mass Index and Parkinson Disease: A Bidirectional Mendelian Randomization Study.
PubMed 文献 · Neurology · 2024-07-10

基于Courage-PD联盟和iPDGC数据,采用两样本孟德尔随机化复制了遗传预测BMI与帕金森病的反向关联,并发现反向关联支持双向关系。

要点

  • 在Courage-PD中,遗传预测BMI与帕金森病呈反向关联(OR 0.82,95%CI 0.70-0.97,p=0.012)。
  • 该关联在年轻参与者(≤67岁,OR 0.71,95%CI 0.55-0.92)和病程较短者(≤7年,OR 0.75,95%CI 0.62-0.91)中趋于更强。
  • 反向MR分析支持遗传易感性 toward 帕金森病与BMI之间存在反向关联。

核心结论

  • 使用独立数据集Courage-PD复制了遗传预测BMI与帕金森病的反向关联,且不能由生存或发病-患病偏倚解释。
  • 反向MR分析支持遗传易感性 toward 帕金森病与BMI之间的反向关联,支持双向关系。

研究设计与样本

  • 两样本孟德尔随机化研究,使用GWAS汇总统计量提取501个单核苷酸多态性(SNPs)与BMI的关联,以及Courage-PD和iPDGC中与帕金森病的关联。
  • 分析基于欧洲血统参与者;BMI汇总统计基于806834名参与者(54%女性)。
  • 帕金森病汇总统计基于Courage-PD的8919例病例(40%女性)和7600例对照(55%女性),以及iPDGC的19438例病例(38%女性)和24388例对照(51%女性)。

主要发现

  • 在Courage-PD中,遗传预测BMI与帕金森病呈反向关联(ORIVW 0.82 [95%CI 0.70-0.97],p=0.012),无多效性证据。
  • 该关联在年轻参与者(≤67岁,ORIVW 0.71 [95%CI 0.55-0.92])和病程较短病例(≤7年,ORIVW 0.75 [95%CI 0.62-0.91])中趋于更强。
  • 在Courage-PD+iPDGC汇总分析中,女性关联(ORIVW 0.85 [95%CI 0.74-0.99],p=0.032)强于男性(ORIVW 0.92 [95%CI 0.80-1.04],p=0.18),但交互作用无统计学意义(p-interaction=0.48)。
  • 反向MR分析有多效性证据,但多效性稳健方法显示遗传易感性 toward 帕金森病与BMI呈显著反向关联。

局限性

  • 反向MR分析中观察到多效性证据。
  • 性别交互作用无统计学意义(p-interaction=0.48)。
  • 分析基于欧洲血统参与者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The role of body mass index (BMI) in Parkinson disease (PD) is unclear. Based on the Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in PD (Courage-PD) consortium, we used 2-sample Mendelian randomization (MR) to replicate a previously reported inverse association of genetically predicted BMI with PD and investigated whether findings were robust in analyses addressing the potential for survival and incidence-prevalence biases. We also examined whether the BMI-PD relation is bidirectional by performing a reverse MR. METHODS: We used summary statistics from a genome-wide association study (GWAS) to extract the association of 501 single-nucleotide polymorphisms (SNPs) with BMI and from the Courage-PD and international Parkinson Disease Genomics Consortium (iPDGC) to estimate their association with PD. Analyses are based on participants of European ancestry. We used the inverse-weighted method to compute odds ratios (ORIVW per 4.8 kg/m2 [95% CI]) of PD and additional pleiotropy robust methods. We performed analyses stratified by age, disease duration, and sex. For reverse MR, we used SNPs associated with PD from 2 iPDGC GWAS to assess the effect of genetic liability toward PD on BMI. RESULTS: Summary statistics for BMI are based on 806,834 participants (54% women). Summary statistics for PD are based on 8,919 (40% women) cases and 7,600 (55% women) controls from Courage-PD, and 19,438 (38% women) cases and 24,388 (51% women) controls from iPDGC. In Courage-PD, we found an inverse association between genetically predicted BMI and PD (ORIVW 0.82 [0.70-0.97], p = 0.012) without evidence for pleiotropy. This association tended to be stronger in younger participants (≤67 years, ORIVW 0.71 [0.55-0.92]) and cases with shorter disease duration (≤7 years, ORIVW 0.75 [0.62-0.91]). In pooled Courage-PD + iPDGC analyses, the association was stronger in women (ORIVW 0.85 [0.74-0.99], p = 0.032) than men (ORIVW 0.92 [0.80-1.04], p = 0.18), but the interaction was not statistically significant (p-interaction = 0.48). In reverse MR, there was evidence for pleiotropy, but pleiotropy robust methods showed a significant inverse association. DISCUSSION: Using an independent data set (Courage-PD), we replicate an inverse association of genetically predicted BMI with PD, not explained by survival or incidence-prevalence biases. Moreover, reverse MR analyses support an inverse association between genetic liability toward PD and BMI, in favor of a bidirectional relation.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Domenighetti C, Sugier PE, Ashok Kumar Sreelatha A, et al. Association of Body Mass Index and Parkinson Disease: A Bidirectional Mendelian Randomization Study. Neurology. 2024. PMID: 38986057. doi:10.1212/WNL.0000000000209620

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。